High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.
复制标题
DOI:
10.1038/s41698-023-00455-z
复制
发表时间:
2023-10-19
影响因子:
7.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Numerous cell states are known to comprise the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME). However, the developmental stemness and co-occurrence of these cell states remain poorly defined. Here, we performed single-cell RNA sequencing (scRNA-seq) on a cohort of treatment-naive PDAC time-of-diagnosis endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) samples (n = 25). We then combined these samples with surgical resection (n = 6) and publicly available samples to increase statistical power (n = 80). Following annotation into 25 distinct cell states, cells were scored for developmental stemness, and a customized version of the Ecotyper tool was used to identify communities of co-occurring cell states in bulk RNA-seq samples (n = 268). We discovered a tumor microenvironmental community comprised of aggressive basal-like malignant cells, tumor-promoting SPP1+ macrophages, and myofibroblastic cancer-associated fibroblasts associated with especially poor prognosis. We also found a developmental stemness continuum with implications for survival that is present in both malignant cells and cancer-associated fibroblasts (CAFs). We further demonstrated that high-dimensional analyses predictive of survival are feasible using standard-of-care, time-of-diagnosis EUS-FNB specimens. In summary, we identified tumor microenvironmental and developmental stemness characteristics from a high-dimensional gene expression analysis of PDAC using human tissue specimens, including time-of-diagnosis EUS-FNB samples. These reveal new connections between tumor microenvironmental composition, CAF and malignant cell stemness, and patient survival that could lead to better upfront risk stratification and more personalized upfront clinical decision-making.
登录
查看更多内容
影响因子:
5.2
作者:
通讯作者:
--
影响因子:
24.5
作者:
Martinelli P;Carrillo-de Santa Pau E;Cox T;Sainz B Jr;Dusetti N;Greenhalf W;Rinaldi L;Costello E;Ghaneh P;Malats N;Büchler M;Pajic M;Biankin AV;Iovanna J;Neoptolemos J;Real FX
通讯作者:
Real FX
影响因子:
12.3
作者:
Lin W;Noel P;Borazanci EH;Lee J;Amini A;Han IW;Heo JS;Jameson GS;Fraser C;Steinbach M;Woo Y;Fong Y;Cridebring D;Von Hoff DD;Park JO;Han H
通讯作者:
Han H
影响因子:
30.8
作者:
Chan-Seng-Yue, Michelle;Kim, Jaeseung C.;Notta, Faiyaz
通讯作者:
Notta, Faiyaz
影响因子:
28.2
作者:
Elyada, Ela;Bolisetty, Mohan;Tuveson, David A.
通讯作者:
Tuveson, David A.